位置:首页 > 蛋白库 > EGFLA_MOUSE
EGFLA_MOUSE
ID   EGFLA_MOUSE             Reviewed;        1017 AA.
AC   Q4VBE4; B2RWU6; B6JU28; Q80WX4; Q8BGP3;
DT   02-OCT-2007, integrated into UniProtKB/Swiss-Prot.
DT   05-JUL-2005, sequence version 1.
DT   03-AUG-2022, entry version 129.
DE   RecName: Full=Pikachurin;
DE   AltName: Full=EGF-like, fibronectin type-III and laminin G-like domain-containing protein;
DE   AltName: Full=Nectican;
DE   Flags: Precursor;
GN   Name=Egflam;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, INTERACTION WITH DAG1
RP   ALPHA-DYSTROGLYCAN, SUBCELLULAR LOCATION, TISSUE SPECIFICITY, DEVELOPMENTAL
RP   STAGE, AND DISRUPTION PHENOTYPE.
RC   TISSUE=Embryo;
RX   PubMed=18641643; DOI=10.1038/nn.2160;
RA   Sato S., Omori Y., Katoh K., Kondo M., Kanagawa M., Miyata K., Funabiki K.,
RA   Koyasu T., Kajimura N., Miyoshi T., Sawai H., Kobayashi K., Tani A.,
RA   Toda T., Usukura J., Tano Y., Fujikado T., Furukawa T.;
RT   "Pikachurin, a dystroglycan ligand, is essential for photoreceptor ribbon
RT   synapse formation.";
RL   Nat. Neurosci. 11:923-931(2008).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   STRAIN=C57BL/6J; TISSUE=Forelimb, Skin, Testis, and Thymus;
RX   PubMed=16141072; DOI=10.1126/science.1112014;
RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M., Davis M.J.,
RA   Wilming L.G., Aidinis V., Allen J.E., Ambesi-Impiombato A., Apweiler R.,
RA   Aturaliya R.N., Bailey T.L., Bansal M., Baxter L., Beisel K.W., Bersano T.,
RA   Bono H., Chalk A.M., Chiu K.P., Choudhary V., Christoffels A.,
RA   Clutterbuck D.R., Crowe M.L., Dalla E., Dalrymple B.P., de Bono B.,
RA   Della Gatta G., di Bernardo D., Down T., Engstrom P., Fagiolini M.,
RA   Faulkner G., Fletcher C.F., Fukushima T., Furuno M., Futaki S.,
RA   Gariboldi M., Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N., Hill D.,
RA   Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T., Jakt M.,
RA   Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H., Kitano H.,
RA   Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K., Kurochkin I.V.,
RA   Lareau L.F., Lazarevic D., Lipovich L., Liu J., Liuni S., McWilliam S.,
RA   Madan Babu M., Madera M., Marchionni L., Matsuda H., Matsuzawa S., Miki H.,
RA   Mignone F., Miyake S., Morris K., Mottagui-Tabar S., Mulder N., Nakano N.,
RA   Nakauchi H., Ng P., Nilsson R., Nishiguchi S., Nishikawa S., Nori F.,
RA   Ohara O., Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G.,
RA   Pesole G., Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z.,
RA   Ringwald M., Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B., Sperling S.,
RA   Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K., Tammoja K.,
RA   Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A., Ueda H.R.,
RA   van Nimwegen E., Verardo R., Wei C.L., Yagi K., Yamanishi H.,
RA   Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C., Grimmond S.M.,
RA   Teasdale R.D., Liu E.T., Brusic V., Quackenbush J., Wahlestedt C.,
RA   Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y., Fukuda S.,
RA   Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T., Iida J., Imamura K.,
RA   Itoh M., Kato T., Kawaji H., Kawagashira N., Kawashima T., Kojima M.,
RA   Kondo S., Konno H., Nakano K., Ninomiya N., Nishio T., Okada M., Plessy C.,
RA   Shibata K., Shiraki T., Suzuki S., Tagami M., Waki K., Watahiki A.,
RA   Okamura-Oho Y., Suzuki H., Kawai J., Hayashizaki Y.;
RT   "The transcriptional landscape of the mammalian genome.";
RL   Science 309:1559-1563(2005).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=C57BL/6J;
RX   PubMed=19468303; DOI=10.1371/journal.pbio.1000112;
RA   Church D.M., Goodstadt L., Hillier L.W., Zody M.C., Goldstein S., She X.,
RA   Bult C.J., Agarwala R., Cherry J.L., DiCuccio M., Hlavina W., Kapustin Y.,
RA   Meric P., Maglott D., Birtle Z., Marques A.C., Graves T., Zhou S.,
RA   Teague B., Potamousis K., Churas C., Place M., Herschleb J., Runnheim R.,
RA   Forrest D., Amos-Landgraf J., Schwartz D.C., Cheng Z., Lindblad-Toh K.,
RA   Eichler E.E., Ponting C.P.;
RT   "Lineage-specific biology revealed by a finished genome assembly of the
RT   mouse.";
RL   PLoS Biol. 7:E1000112-E1000112(2009).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Brain, Eye, and Olfactory epithelium;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   FUNCTION, GLYCOSYLATION, SUBCELLULAR LOCATION, AND DEVELOPMENTAL STAGE.
RX   PubMed=18757743; DOI=10.1073/pnas.0803640105;
RA   Manabe R., Tsutsui K., Yamada T., Kimura M., Nakano I., Shimono C.,
RA   Sanzen N., Furutani Y., Fukuda T., Oguri Y., Shimamoto K., Kiyozumi D.,
RA   Sato Y., Sado Y., Senoo H., Yamashina S., Fukuda S., Kawai J., Sugiura N.,
RA   Kimata K., Hayashizaki Y., Sekiguchi K.;
RT   "Transcriptome-based systematic identification of extracellular matrix
RT   proteins.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:12849-12854(2008).
RN   [6]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Lung;
RX   PubMed=21183079; DOI=10.1016/j.cell.2010.12.001;
RA   Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R.,
RA   Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.;
RT   "A tissue-specific atlas of mouse protein phosphorylation and expression.";
RL   Cell 143:1174-1189(2010).
CC   -!- FUNCTION: Involved in both the retinal photoreceptor ribbon synapse
CC       formation and physiological functions of visual perception. Necessary
CC       for proper bipolar dendritic tip apposition to the photoreceptor ribbon
CC       synapse. Promotes matrix assembly and cell adhesiveness.
CC       {ECO:0000269|PubMed:18641643, ECO:0000269|PubMed:18757743}.
CC   -!- SUBUNIT: Interacts with DAG1 alpha-dystroglycan.
CC       {ECO:0000269|PubMed:18641643}.
CC   -!- INTERACTION:
CC       Q4VBE4; PRO_0000021067 [Q62165]: Dag1; NbExp=2; IntAct=EBI-2025048, EBI-2025154;
CC       Q4VBE4; Q6PRD1: GPR179; Xeno; NbExp=3; IntAct=EBI-2025048, EBI-20895185;
CC   -!- SUBCELLULAR LOCATION: Secreted, extracellular space, extracellular
CC       matrix {ECO:0000269|PubMed:18757743}. Synaptic cleft
CC       {ECO:0000269|PubMed:18641643}. Presynaptic active zone
CC       {ECO:0000269|PubMed:18641643}. Note=Detected in the synaptic cleft of
CC       the ribbon synapse around the postsynaptic terminals of bipolar cells
CC       (PubMed:18641643). Colocalizes with BSN, CTBP2 and DAG1 in
CC       photoreceptor synaptic terminals (PubMed:18641643).
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q4VBE4-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q4VBE4-2; Sequence=VSP_028482;
CC   -!- TISSUE SPECIFICITY: Expressed in the outer plexiform layer (first
CC       synaptic region) but not in the inner plexiform layer (second synaptic
CC       region) of the retina (at protein level). Strongly expressed in the
CC       photoreceptor layer of the retina. Moderately expressed in pineal gland
CC       and brain. Weakly expressed in lung and ovary.
CC       {ECO:0000269|PubMed:18641643}.
CC   -!- DEVELOPMENTAL STAGE: Expressed in the apical side of the neuroblastic
CC       layer (NBL) of the retina at 14.5 dpc and 17.5 dpc. At 16.5 dpc,
CC       present in rib cartilage and hair follicle (at protein level).
CC       {ECO:0000269|PubMed:18641643, ECO:0000269|PubMed:18757743}.
CC   -!- PTM: O-glycosylated; contains chondroitin sulfate and heparan sulfate.
CC       {ECO:0000269|PubMed:18757743}.
CC   -!- DISRUPTION PHENOTYPE: No morphological abnormalities. Knockout mice are
CC       viable and fertile. However, the terminal of bipolar cells do not
CC       appose to the synapse terminals in the rod photoreceptor ribbon
CC       synapses. The signal transmission from the rod photoreceptor to the rod
CC       bipolar cells is less sensitive and is delayed compared to the wild
CC       type mouse. The signal transmission from cone photoreceptors to the
CC       cone bipolar cells is also impaired. These mice show reduced visual
CC       function. {ECO:0000269|PubMed:18641643}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; DQ223720; ABB48431.1; -; mRNA.
DR   EMBL; AK031136; BAC27271.1; -; mRNA.
DR   EMBL; AK033332; BAC28235.1; -; mRNA.
DR   EMBL; AK037223; BAC29762.1; -; mRNA.
DR   EMBL; AK041546; BAC30982.1; -; mRNA.
DR   EMBL; AC105969; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC158747; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC051455; AAH51455.1; -; mRNA.
DR   EMBL; BC095994; AAH95994.1; -; mRNA.
DR   EMBL; BC150710; AAI50711.1; -; mRNA.
DR   CCDS; CCDS27370.1; -. [Q4VBE4-2]
DR   CCDS; CCDS79359.1; -. [Q4VBE4-1]
DR   RefSeq; NP_001276425.1; NM_001289496.1. [Q4VBE4-1]
DR   RefSeq; NP_848863.1; NM_178748.6. [Q4VBE4-2]
DR   RefSeq; XP_017172117.1; XM_017316628.1. [Q4VBE4-2]
DR   AlphaFoldDB; Q4VBE4; -.
DR   SMR; Q4VBE4; -.
DR   BioGRID; 234554; 1.
DR   IntAct; Q4VBE4; 6.
DR   STRING; 10090.ENSMUSP00000055599; -.
DR   GlyGen; Q4VBE4; 1 site.
DR   PhosphoSitePlus; Q4VBE4; -.
DR   MaxQB; Q4VBE4; -.
DR   PaxDb; Q4VBE4; -.
DR   PRIDE; Q4VBE4; -.
DR   ProteomicsDB; 277561; -. [Q4VBE4-1]
DR   ProteomicsDB; 277562; -. [Q4VBE4-2]
DR   Antibodypedia; 23033; 117 antibodies from 20 providers.
DR   DNASU; 268780; -.
DR   Ensembl; ENSMUST00000058593; ENSMUSP00000055599; ENSMUSG00000042961. [Q4VBE4-2]
DR   Ensembl; ENSMUST00000096494; ENSMUSP00000094238; ENSMUSG00000042961. [Q4VBE4-1]
DR   GeneID; 268780; -.
DR   KEGG; mmu:268780; -.
DR   UCSC; uc007vea.2; mouse. [Q4VBE4-2]
DR   UCSC; uc007veb.2; mouse. [Q4VBE4-1]
DR   CTD; 133584; -.
DR   MGI; MGI:2146149; Egflam.
DR   VEuPathDB; HostDB:ENSMUSG00000042961; -.
DR   eggNOG; KOG0613; Eukaryota.
DR   eggNOG; KOG3509; Eukaryota.
DR   GeneTree; ENSGT00940000158504; -.
DR   HOGENOM; CLU_013380_0_0_1; -.
DR   InParanoid; Q4VBE4; -.
DR   OMA; ISIQYPQ; -.
DR   OrthoDB; 414294at2759; -.
DR   PhylomeDB; Q4VBE4; -.
DR   TreeFam; TF326548; -.
DR   BioGRID-ORCS; 268780; 3 hits in 73 CRISPR screens.
DR   ChiTaRS; Egflam; mouse.
DR   PRO; PR:Q4VBE4; -.
DR   Proteomes; UP000000589; Chromosome 15.
DR   RNAct; Q4VBE4; protein.
DR   Bgee; ENSMUSG00000042961; Expressed in retinal neural layer and 154 other tissues.
DR   ExpressionAtlas; Q4VBE4; baseline and differential.
DR   Genevisible; Q4VBE4; MM.
DR   GO; GO:0070161; C:anchoring junction; IEA:UniProtKB-KW.
DR   GO; GO:0005604; C:basement membrane; IDA:MGI.
DR   GO; GO:0042995; C:cell projection; IEA:UniProtKB-KW.
DR   GO; GO:0031012; C:extracellular matrix; IDA:MGI.
DR   GO; GO:0005614; C:interstitial matrix; IDA:MGI.
DR   GO; GO:0048786; C:presynaptic active zone; IEA:UniProtKB-SubCell.
DR   GO; GO:0043083; C:synaptic cleft; IEA:UniProtKB-SubCell.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   GO; GO:0005539; F:glycosaminoglycan binding; IDA:MGI.
DR   GO; GO:0009887; P:animal organ morphogenesis; IBA:GO_Central.
DR   GO; GO:0030198; P:extracellular matrix organization; IDA:MGI.
DR   GO; GO:0019800; P:peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan; IDA:MGI.
DR   GO; GO:0010811; P:positive regulation of cell-substrate adhesion; IDA:MGI.
DR   GO; GO:0009888; P:tissue development; IBA:GO_Central.
DR   CDD; cd00063; FN3; 2.
DR   CDD; cd00110; LamG; 3.
DR   Gene3D; 2.60.40.10; -; 2.
DR   InterPro; IPR013320; ConA-like_dom_sf.
DR   InterPro; IPR001881; EGF-like_Ca-bd_dom.
DR   InterPro; IPR000742; EGF-like_dom.
DR   InterPro; IPR003961; FN3_dom.
DR   InterPro; IPR036116; FN3_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR001791; Laminin_G.
DR   Pfam; PF00008; EGF; 2.
DR   Pfam; PF00041; fn3; 2.
DR   Pfam; PF00054; Laminin_G_1; 1.
DR   Pfam; PF02210; Laminin_G_2; 2.
DR   SMART; SM00181; EGF; 3.
DR   SMART; SM00179; EGF_CA; 2.
DR   SMART; SM00060; FN3; 2.
DR   SMART; SM00282; LamG; 3.
DR   SUPFAM; SSF49265; SSF49265; 1.
DR   SUPFAM; SSF49899; SSF49899; 3.
DR   PROSITE; PS00022; EGF_1; 3.
DR   PROSITE; PS01186; EGF_2; 2.
DR   PROSITE; PS50026; EGF_3; 3.
DR   PROSITE; PS50853; FN3; 2.
DR   PROSITE; PS50025; LAM_G_DOMAIN; 3.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cell projection; Disulfide bond; EGF-like domain;
KW   Extracellular matrix; Glycoprotein; Reference proteome; Repeat; Secreted;
KW   Signal; Synapse.
FT   SIGNAL          1..24
FT                   /evidence="ECO:0000255"
FT   CHAIN           25..1017
FT                   /note="Pikachurin"
FT                   /id="PRO_0000306804"
FT   DOMAIN          37..136
FT                   /note="Fibronectin type-III 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          144..239
FT                   /note="Fibronectin type-III 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          343..381
FT                   /note="EGF-like 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DOMAIN          386..564
FT                   /note="Laminin G-like 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00122"
FT   DOMAIN          565..602
FT                   /note="EGF-like 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DOMAIN          609..788
FT                   /note="Laminin G-like 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00122"
FT   DOMAIN          784..820
FT                   /note="EGF-like 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DOMAIN          835..1014
FT                   /note="Laminin G-like 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00122"
FT   CARBOHYD        47
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        347..358
FT                   /evidence="ECO:0000250"
FT   DISULFID        352..369
FT                   /evidence="ECO:0000250"
FT   DISULFID        371..380
FT                   /evidence="ECO:0000250"
FT   DISULFID        534..564
FT                   /evidence="ECO:0000250"
FT   DISULFID        569..580
FT                   /evidence="ECO:0000250"
FT   DISULFID        574..590
FT                   /evidence="ECO:0000250"
FT   DISULFID        592..601
FT                   /evidence="ECO:0000250"
FT   DISULFID        788..799
FT                   /evidence="ECO:0000250"
FT   DISULFID        793..808
FT                   /evidence="ECO:0000250"
FT   DISULFID        810..819
FT                   /evidence="ECO:0000250"
FT   DISULFID        987..1014
FT                   /evidence="ECO:0000250"
FT   VAR_SEQ         822..830
FT                   /note="ECGNHCLNT -> A (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334,
FT                   ECO:0000303|PubMed:16141072"
FT                   /id="VSP_028482"
FT   CONFLICT        45
FT                   /note="A -> T (in Ref. 4; AAI50711)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   1017 AA;  110735 MW;  F8A21D89B251D455 CRC64;
     MDLISTFSLH FLLLACSLPP GAVSLRTALR KSGKVGPPLD IKLGALNCTA FSIQWKTPKR
     SGSSIIGYTV FYSEVGSDKS LRERSHNVPV GQDTLITEEV IGDLKPGTEY QVSVAAYSQT
     GKGRLSFPRH VTTLSQDSCL PPAAPQQPHV LVVSDSEVAL SWRPGENEGS APIQSYSVEF
     IRPDFDKSWT IIQERLQMDS MVIKGLDPDT NYQFAVKAMN AHGFSPRSWP SNTVRTLGPG
     EAGSGHYGPG YITNPGVSED DDGSEDELDL DVSFEEVKPL PATKVGNKKF SVESKKTSVS
     NSVMGSRLAQ PTSASLHETT VAIPPTPAQR KGKNSVAMMS RLFDMSCDET LCSADSFCVN
     DYAWGGSRCH CNLGKGGEAC SEDIFIQYPQ FFGHSYVTFE PLKNSYQAFQ VTLEFRAEAE
     DGLLLYCGES EHGRGDFMSL ALIRRSLHFR FNCGTGIAII ISETKIKLGA WHTVTLYRDG
     LNGMLQLNNG TPVTGQSQGQ YSKITFRTPL YLGGAPSAYW LVRATGTNRG FQGCVQSLSV
     NGKKIDMRPW PLGKALNGAD VGECSSGICD EASCIHGGTC AAIKADSYIC LCPLGFRGRH
     CEDAFALTIP QFRESLRSYA ATPWPLEPQH YLSFTEFEIT FRPDSGDGVL LYSYDTGSKD
     FLSINMAAGH VEFRFDCGSG TGVLRSEAPL TLGQWHDLRV SRTAKNGILQ VDKQKVVEGM
     AEGGFTQIKC NTDIFIGGVP NYDDVKKNSG ILHPFSGSIQ KIILNDRTIH VKHDFTSGVN
     VENAAHPCVG APCAHGGSCR PRKEGYECDC PLGFEGLNCQ KECGNHCLNT IIEAIEIPQF
     IGRSYLTYDN PNILKRVSGS RSNAFMRFKT TAKDGLLLWR GDSPMRPNSD FISLGLRDGA
     LIFSYNLGSG VASIMVNGSF SDGRWHRVKA VRDGQSGKIT VDDYGARTGK SPGLMRQLNI
     NGALYVGGMK EIALHTNRQY LRGLVGCISH FTLSTDYHIS LVEDAVDGKN INTCGAK
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024